0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erdosteine Capsules Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11B14893
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Erdosteine Capsules Market Research Report 2023
BUY CHAPTERS

Global Erdosteine Capsules Market Research Report 2025

Code: QYRE-Auto-11B14893
Report
May 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Erdosteine Capsules Market

The global market for Erdosteine Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Erdosteine ​​Capsules is a drug whose main ingredient is Erdosteine. Erdosteine ​​is a mucolytic and mucus regulator that is widely used in the treatment of respiratory diseases.
North American market for Erdosteine Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Erdosteine Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Erdosteine Capsules include Famar Italia SpA, Zhejiang Kangle Pharmaceutical Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Xi'an Haixin Pharmaceutical Co., Ltd., Shanghai Pukang Pharmaceutical Industry Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erdosteine Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erdosteine Capsules.
The Erdosteine Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erdosteine Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erdosteine Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Erdosteine Capsules Market Report

Report Metric Details
Report Name Erdosteine Capsules Market
Segment by Type
  • 150mg
  • 300mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Famar Italia SpA, Zhejiang Kangle Pharmaceutical Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Xi'an Haixin Pharmaceutical Co., Ltd., Shanghai Pukang Pharmaceutical Industry Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Erdosteine Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Erdosteine Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Erdosteine Capsules Market report?

Ans: The main players in the Erdosteine Capsules Market are Famar Italia SpA, Zhejiang Kangle Pharmaceutical Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Xi'an Haixin Pharmaceutical Co., Ltd., Shanghai Pukang Pharmaceutical Industry Co., Ltd.

What are the Application segmentation covered in the Erdosteine Capsules Market report?

Ans: The Applications covered in the Erdosteine Capsules Market report are Hospital, Clinic, Retail Pharmacy, Others

What are the Type segmentation covered in the Erdosteine Capsules Market report?

Ans: The Types covered in the Erdosteine Capsules Market report are 150mg, 300mg

Recommended Reports

Pharmaceutical Capsules

Therapeutic Drugs

Capsule Devices

1 Erdosteine Capsules Market Overview
1.1 Product Definition
1.2 Erdosteine Capsules by Type
1.2.1 Global Erdosteine Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 150mg
1.2.3 300mg
1.3 Erdosteine Capsules by Application
1.3.1 Global Erdosteine Capsules Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Others
1.4 Global Erdosteine Capsules Market Size Estimates and Forecasts
1.4.1 Global Erdosteine Capsules Revenue 2020-2031
1.4.2 Global Erdosteine Capsules Sales 2020-2031
1.4.3 Global Erdosteine Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erdosteine Capsules Market Competition by Manufacturers
2.1 Global Erdosteine Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erdosteine Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erdosteine Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erdosteine Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erdosteine Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erdosteine Capsules, Product Type & Application
2.7 Global Key Manufacturers of Erdosteine Capsules, Date of Enter into This Industry
2.8 Global Erdosteine Capsules Market Competitive Situation and Trends
2.8.1 Global Erdosteine Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erdosteine Capsules Players Market Share by Revenue
2.8.3 Global Erdosteine Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erdosteine Capsules Market Scenario by Region
3.1 Global Erdosteine Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erdosteine Capsules Sales by Region: 2020-2031
3.2.1 Global Erdosteine Capsules Sales by Region: 2020-2025
3.2.2 Global Erdosteine Capsules Sales by Region: 2026-2031
3.3 Global Erdosteine Capsules Revenue by Region: 2020-2031
3.3.1 Global Erdosteine Capsules Revenue by Region: 2020-2025
3.3.2 Global Erdosteine Capsules Revenue by Region: 2026-2031
3.4 North America Erdosteine Capsules Market Facts & Figures by Country
3.4.1 North America Erdosteine Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erdosteine Capsules Sales by Country (2020-2031)
3.4.3 North America Erdosteine Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erdosteine Capsules Market Facts & Figures by Country
3.5.1 Europe Erdosteine Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erdosteine Capsules Sales by Country (2020-2031)
3.5.3 Europe Erdosteine Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erdosteine Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Erdosteine Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erdosteine Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Erdosteine Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Erdosteine Capsules Market Facts & Figures by Country
3.7.1 Latin America Erdosteine Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erdosteine Capsules Sales by Country (2020-2031)
3.7.3 Latin America Erdosteine Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erdosteine Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Erdosteine Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erdosteine Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erdosteine Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erdosteine Capsules Sales by Type (2020-2031)
4.1.1 Global Erdosteine Capsules Sales by Type (2020-2025)
4.1.2 Global Erdosteine Capsules Sales by Type (2026-2031)
4.1.3 Global Erdosteine Capsules Sales Market Share by Type (2020-2031)
4.2 Global Erdosteine Capsules Revenue by Type (2020-2031)
4.2.1 Global Erdosteine Capsules Revenue by Type (2020-2025)
4.2.2 Global Erdosteine Capsules Revenue by Type (2026-2031)
4.2.3 Global Erdosteine Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Erdosteine Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erdosteine Capsules Sales by Application (2020-2031)
5.1.1 Global Erdosteine Capsules Sales by Application (2020-2025)
5.1.2 Global Erdosteine Capsules Sales by Application (2026-2031)
5.1.3 Global Erdosteine Capsules Sales Market Share by Application (2020-2031)
5.2 Global Erdosteine Capsules Revenue by Application (2020-2031)
5.2.1 Global Erdosteine Capsules Revenue by Application (2020-2025)
5.2.2 Global Erdosteine Capsules Revenue by Application (2026-2031)
5.2.3 Global Erdosteine Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Erdosteine Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Famar Italia SpA
6.1.1 Famar Italia SpA Company Information
6.1.2 Famar Italia SpA Description and Business Overview
6.1.3 Famar Italia SpA Erdosteine Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Famar Italia SpA Erdosteine Capsules Product Portfolio
6.1.5 Famar Italia SpA Recent Developments/Updates
6.2 Zhejiang Kangle Pharmaceutical Co.,Ltd.
6.2.1 Zhejiang Kangle Pharmaceutical Co.,Ltd. Company Information
6.2.2 Zhejiang Kangle Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Zhejiang Kangle Pharmaceutical Co.,Ltd. Erdosteine Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zhejiang Kangle Pharmaceutical Co.,Ltd. Erdosteine Capsules Product Portfolio
6.2.5 Zhejiang Kangle Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.3.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
6.3.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.3.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Erdosteine Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Erdosteine Capsules Product Portfolio
6.3.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.4 Xi'an Haixin Pharmaceutical Co., Ltd.
6.4.1 Xi'an Haixin Pharmaceutical Co., Ltd. Company Information
6.4.2 Xi'an Haixin Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Xi'an Haixin Pharmaceutical Co., Ltd. Erdosteine Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xi'an Haixin Pharmaceutical Co., Ltd. Erdosteine Capsules Product Portfolio
6.4.5 Xi'an Haixin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Shanghai Pukang Pharmaceutical Industry Co., Ltd.
6.5.1 Shanghai Pukang Pharmaceutical Industry Co., Ltd. Company Information
6.5.2 Shanghai Pukang Pharmaceutical Industry Co., Ltd. Description and Business Overview
6.5.3 Shanghai Pukang Pharmaceutical Industry Co., Ltd. Erdosteine Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Pukang Pharmaceutical Industry Co., Ltd. Erdosteine Capsules Product Portfolio
6.5.5 Shanghai Pukang Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erdosteine Capsules Industry Chain Analysis
7.2 Erdosteine Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erdosteine Capsules Production Mode & Process Analysis
7.4 Erdosteine Capsules Sales and Marketing
7.4.1 Erdosteine Capsules Sales Channels
7.4.2 Erdosteine Capsules Distributors
7.5 Erdosteine Capsules Customer Analysis
8 Erdosteine Capsules Market Dynamics
8.1 Erdosteine Capsules Industry Trends
8.2 Erdosteine Capsules Market Drivers
8.3 Erdosteine Capsules Market Challenges
8.4 Erdosteine Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Erdosteine Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Erdosteine Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Erdosteine Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Erdosteine Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Erdosteine Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Erdosteine Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Erdosteine Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Erdosteine Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Erdosteine Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Erdosteine Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Erdosteine Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Erdosteine Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Erdosteine Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erdosteine Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Erdosteine Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Erdosteine Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Erdosteine Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Erdosteine Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Erdosteine Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Erdosteine Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Erdosteine Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Erdosteine Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Erdosteine Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Erdosteine Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Erdosteine Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Erdosteine Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Erdosteine Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Erdosteine Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Erdosteine Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Erdosteine Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Erdosteine Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Erdosteine Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Erdosteine Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Erdosteine Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Erdosteine Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Erdosteine Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Erdosteine Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Erdosteine Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Erdosteine Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Erdosteine Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Erdosteine Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Erdosteine Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Erdosteine Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Erdosteine Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Erdosteine Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Erdosteine Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Erdosteine Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Erdosteine Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Erdosteine Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Erdosteine Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Erdosteine Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Erdosteine Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Erdosteine Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Erdosteine Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Erdosteine Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Erdosteine Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Erdosteine Capsules Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Erdosteine Capsules Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Erdosteine Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Erdosteine Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Erdosteine Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Erdosteine Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Erdosteine Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Erdosteine Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Erdosteine Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Erdosteine Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Erdosteine Capsules Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Erdosteine Capsules Price (US$/Unit) by Application (2026-2031)
 Table 70. Famar Italia SpA Company Information
 Table 71. Famar Italia SpA Description and Business Overview
 Table 72. Famar Italia SpA Erdosteine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Famar Italia SpA Erdosteine Capsules Product
 Table 74. Famar Italia SpA Recent Developments/Updates
 Table 75. Zhejiang Kangle Pharmaceutical Co.,Ltd. Company Information
 Table 76. Zhejiang Kangle Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 77. Zhejiang Kangle Pharmaceutical Co.,Ltd. Erdosteine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zhejiang Kangle Pharmaceutical Co.,Ltd. Erdosteine Capsules Product
 Table 79. Zhejiang Kangle Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 80. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
 Table 81. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
 Table 82. Yangtze River Pharmaceutical (Group) Co., Ltd. Erdosteine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Yangtze River Pharmaceutical (Group) Co., Ltd. Erdosteine Capsules Product
 Table 84. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
 Table 85. Xi'an Haixin Pharmaceutical Co., Ltd. Company Information
 Table 86. Xi'an Haixin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Xi'an Haixin Pharmaceutical Co., Ltd. Erdosteine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Xi'an Haixin Pharmaceutical Co., Ltd. Erdosteine Capsules Product
 Table 89. Xi'an Haixin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Shanghai Pukang Pharmaceutical Industry Co., Ltd. Company Information
 Table 91. Shanghai Pukang Pharmaceutical Industry Co., Ltd. Description and Business Overview
 Table 92. Shanghai Pukang Pharmaceutical Industry Co., Ltd. Erdosteine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shanghai Pukang Pharmaceutical Industry Co., Ltd. Erdosteine Capsules Product
 Table 94. Shanghai Pukang Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Erdosteine Capsules Distributors List
 Table 98. Erdosteine Capsules Customers List
 Table 99. Erdosteine Capsules Market Trends
 Table 100. Erdosteine Capsules Market Drivers
 Table 101. Erdosteine Capsules Market Challenges
 Table 102. Erdosteine Capsules Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Erdosteine Capsules
 Figure 2. Global Erdosteine Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Erdosteine Capsules Market Share by Type: 2024 & 2031
 Figure 4. 150mg Product Picture
 Figure 5. 300mg Product Picture
 Figure 6. Global Erdosteine Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Erdosteine Capsules Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Retail Pharmacy
 Figure 11. Others
 Figure 12. Global Erdosteine Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Erdosteine Capsules Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Erdosteine Capsules Sales (2020-2031) & (K Units)
 Figure 15. Global Erdosteine Capsules Average Price (US$/Unit) & (2020-2031)
 Figure 16. Erdosteine Capsules Report Years Considered
 Figure 17. Erdosteine Capsules Sales Share by Manufacturers in 2024
 Figure 18. Global Erdosteine Capsules Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Erdosteine Capsules Players: Market Share by Revenue in Erdosteine Capsules in 2024
 Figure 20. Erdosteine Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Erdosteine Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Erdosteine Capsules Sales Market Share by Country (2020-2031)
 Figure 23. North America Erdosteine Capsules Revenue Market Share by Country (2020-2031)
 Figure 24. United States Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Erdosteine Capsules Sales Market Share by Country (2020-2031)
 Figure 27. Europe Erdosteine Capsules Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Erdosteine Capsules Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Erdosteine Capsules Revenue Market Share by Region (2020-2031)
 Figure 35. China Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Erdosteine Capsules Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Erdosteine Capsules Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Erdosteine Capsules Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Erdosteine Capsules Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Erdosteine Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Erdosteine Capsules by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Erdosteine Capsules by Type (2020-2031)
 Figure 54. Global Erdosteine Capsules Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Erdosteine Capsules by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Erdosteine Capsules by Application (2020-2031)
 Figure 57. Global Erdosteine Capsules Price (US$/Unit) by Application (2020-2031)
 Figure 58. Erdosteine Capsules Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure